CR11766A - Derivados de iminopiridina y uso de los mismos - Google Patents

Derivados de iminopiridina y uso de los mismos

Info

Publication number
CR11766A
CR11766A CR11766A CR11766A CR11766A CR 11766 A CR11766 A CR 11766A CR 11766 A CR11766 A CR 11766A CR 11766 A CR11766 A CR 11766A CR 11766 A CR11766 A CR 11766A
Authority
CR
Costa Rica
Prior art keywords
iminopiridine
derivatives
same
prophylactic
useful
Prior art date
Application number
CR11766A
Other languages
English (en)
Inventor
Masato Yoshida
Yasuhisa Kohara
Nobuki Sakauchi
Ayumu Sato
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CR11766A publication Critical patent/CR11766A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe un compuesto el cual tiene una excelente actividad selectiva superior como antagonista del receptor adrenergico 1D y por lo tanto es util como un agente profilactico/terapeutico para el tratamiento de una enfermedad del tracto urinario inferior y similares.
CR11766A 2008-04-23 2010-10-27 Derivados de iminopiridina y uso de los mismos CR11766A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008113130 2008-04-23

Publications (1)

Publication Number Publication Date
CR11766A true CR11766A (es) 2010-12-15

Family

ID=41216865

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11766A CR11766A (es) 2008-04-23 2010-10-27 Derivados de iminopiridina y uso de los mismos

Country Status (16)

Country Link
US (1) US20110039892A1 (es)
EP (1) EP2269989A4 (es)
JP (1) JPWO2009131135A1 (es)
KR (1) KR20110005277A (es)
CN (1) CN102066328A (es)
AU (1) AU2009238999A1 (es)
BR (1) BRPI0911464A2 (es)
CA (1) CA2722031A1 (es)
CO (1) CO6260133A2 (es)
CR (1) CR11766A (es)
DO (1) DOP2010000322A (es)
EA (1) EA201071228A1 (es)
EC (1) ECSP10010625A (es)
IL (1) IL208824A0 (es)
MX (1) MX2010011651A (es)
WO (1) WO2009131135A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2077262A4 (en) * 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVE AND USE THEREOF
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN103781764B (zh) * 2011-08-26 2016-07-20 明治制果药业株式会社 有害生物防除剂的制造法
EP4433469A1 (en) * 2021-11-15 2024-09-25 PI Industries Ltd. Bicyclic heteroaromatic compounds and their use as pest control agents

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4840544B1 (es) 1970-04-24 1973-12-01
DD106377A1 (es) 1973-06-18 1974-06-12
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.
GR78245B (es) 1980-09-12 1984-09-26 Ciba Geigy Ag
FR2540109B1 (fr) * 1983-01-28 1985-08-30 Logeais Labor Jacques Imino-2 pyrrolidines, leur procede de preparation et leurs applications en therapeutique
DD263759A1 (de) 1986-04-01 1989-01-11 Akad Wissenschaften Ddr Verfahren zur herstellung von 1-substituierten 2-imino-5-(pyrid-4-yl)-1,2-dihydro-pyridin-3-carbonsaeure-derivaten
US5252498A (en) * 1989-08-28 1993-10-12 Semiconductor Energy Laboratory Co., Ltd. Method of forming electronic devices utilizing diamond
DE4021439A1 (de) * 1989-12-14 1991-06-20 Bayer Ag 2-iminopyridin-derivate
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
JP2992677B2 (ja) 1995-06-05 1999-12-20 武田薬品工業株式会社 骨形成促進医薬組成物
US6218396B1 (en) * 1998-02-20 2001-04-17 Orth-Mcneil Pharmaceutical, Inc. Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
US6153614A (en) * 1998-07-16 2000-11-28 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
WO2000004012A1 (en) * 1998-07-17 2000-01-27 Synaptic Pharmaceutical Corporation COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF
DE19845202A1 (de) * 1998-10-01 2000-04-06 Wella Ag Haarwuchsmittel
DE60137273D1 (de) * 2000-10-20 2009-02-12 Eisai R&D Man Co Ltd Verfahren zur Herstellung von 4-Phenoxy chinolin Derivaten
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
US7375100B2 (en) * 2003-06-04 2008-05-20 Pfizer Inc 2-amino-pyridine derivatives useful for the treatment of diseases
ES2241496B1 (es) * 2004-04-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridina.
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
TW200700392A (en) * 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
ES2303758B1 (es) * 2006-02-20 2009-08-13 Laboratorios Almirall S.A. Nuevos derivados de piridin-3-amina.
EP2077262A4 (en) * 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVE AND USE THEREOF
JP4117008B2 (ja) 2006-10-30 2008-07-09 シャープ株式会社 暗号化装置
JP5241834B2 (ja) * 2007-07-19 2013-07-17 メルク・シャープ・アンド・ドーム・コーポレーション プロテインキナーゼ阻害剤としての複素環アミド化合物
AU2009227013B2 (en) * 2008-03-21 2013-01-10 Novartis Ag Novel heterocyclic compounds and uses therof
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CL2009000964A1 (es) * 2008-04-23 2010-03-26 Takeda Pharmaceuticals Co Compuestos derivados de 1-aril-2-imino-1,2-dihidropiridina-3-carboxamida, antagonista del receptor adrenergico alfa 1d, composicion farmaceutica que los comprende; y su uso para el tratamiento o profilaxis de enfermedades del tracto urinario inferior.

Also Published As

Publication number Publication date
KR20110005277A (ko) 2011-01-17
EP2269989A1 (en) 2011-01-05
CA2722031A1 (en) 2009-10-29
ECSP10010625A (es) 2011-03-31
DOP2010000322A (es) 2011-01-31
CN102066328A (zh) 2011-05-18
CO6260133A2 (es) 2011-03-22
BRPI0911464A2 (pt) 2016-07-12
EA201071228A1 (ru) 2011-06-30
IL208824A0 (en) 2011-01-31
WO2009131135A1 (ja) 2009-10-29
JPWO2009131135A1 (ja) 2011-08-18
US20110039892A1 (en) 2011-02-17
AU2009238999A1 (en) 2009-10-29
EP2269989A4 (en) 2011-05-25
MX2010011651A (es) 2010-12-06

Similar Documents

Publication Publication Date Title
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
CL2008003595A1 (es) Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central.
ECSP088210A (es) Bencimidazoles sustituidos y métodos de preparación
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
CO6541645A2 (es) Compuestos de indol y su uso farmaceutico
CL2011003229A1 (es) Compuestos conjugados derivados de criptoficina; procedimiento de preparacion; y su uso para el tratamiento del cancer.
ECSP10010390A (es) Compuestos
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
CL2007002188A1 (es) Compuestos derivados de heteroarilaminas; procedimiento de preparacion; composicion farmceutica; y uso del compuesto para tratar el crecimiento celular anormal.
CL2009000545A1 (es) Uso de un antagonista de c-met y un antagonista de her para el tratamiento de cancer.
CL2009001058A1 (es) Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
UY32882A (es) (heteroarilmetil) tiohidantoínas sustituidas
GT201200147A (es) Antagonistas de espiro-oxindol de mdm2
CR20120177A (es) Nuevos compuestos de espiropiperidina y el uso farmacéutico del mismo para el tratamiento de diabetes
ECSP088989A (es) (aza)ciclohexanos carboxilados nuevos como ligandos de receptores de dopamina d3
CR20120448A (es) Compuesto heterocíclico
BRPI0912988A2 (pt) compostos bicíclicos tendo atividade no receptor cxcr4.
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
ECSP11011294A (es) Compuestos de anillo fusionados y su uso
DOP2010000321A (es) Derivados de iminopirimidina y su uso
ECSP099675A (es) Compuestos heterocíclicos, composición y métodos de uso
MX2011011058A (es) Antagonistas del receptor ep4 para el tratamiento de cancer.
ECSP10010168A (es) Benzotiazolas como moduladores del receptor de ghrelina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)